| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |